Location: Bay Area, California, USA.
Based on news reporting.
Gilead Sciences, Inc., a major HIV drug manufacturer, is set to lay off nearly 150 employees in the Bay Area. This decision comes as part of a broader restructuring effort aimed at streamlining operations and reducing costs. The layoffs are expected to take effect shortly, impacting various roles within the company. Gilead's leadership has indicated that these cuts are necessary to align with the company's strategic goals and respond to market dynamics. The affected employees will be notified soon, and the company is committed to providing support during this transition.
Gilead Sciences, Inc. cut 150 jobs as of October 1, 2023.
That is roughly 0.8% of the 18,000 people Gilead Sciences, Inc. employs.
LayoffTalk has tracked 16 layoff events at Gilead Sciences, Inc. since October 2023, affecting a combined 1,581 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
Gilead Sciences, Inc. cut 150 jobs on October 1, 2023. If you were part of this round, what was your experience? Others going through it are reading. You can post anonymously below.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.